U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07643233) titled 'Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed Conditions' on June 08.
Brief Summary: To evaluate and compare the safety and pharmacokinetic profiles of "AJU-G721" (test drug) and "G721R" (reference drug) in healthy adult male subjects.
Study Start Date: July, 2026
Study Type: INTERVENTIONAL
Condition:
Moderate-to-severe Benign Prostatic Hyperplasia (BPH)
Intervention:
DRUG: Test Drug
AJU-G721
DRUG: Reference Drug
G721R
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AJU Pharm Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....